Clinical Trials Directory

Trials / Completed

CompletedNCT03212430

The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

To measure the cerebral hemodynamic effect of L-kynurenine.

Detailed description

Aim: To investigate the physiological effect of L-Kynurenine after intravenous administration to healthy volunteers. Hypothesis: L-kynurenine induces vasodilation in the cerebral vessels and trigger headache in healthy individuals. Methods: 6 healthy volunteers will receive intravenous infusion of L-kynurenine using the following doses 50 microgram/kg, 100 microgram/kg, 150 microgram/kg, 300 microgram/kg, 500 microgram/kg, 1 mg/kg and 5 mg/kg over 20 min on 7 different days with at least 1 day in between. Before and after infusion (at 20, 40, 60, 80 and 100 min) we will record vital signs, circumferences of middle cerebral artery, superficial temporalis artery and headache intensity and characteristics. The subjects will then have a questionnaire about headache for the following 24 hours.

Conditions

Interventions

TypeNameDescription
DRUGL-kynurenineintravenous infusion of L-kynurenine to healthy individuals.

Timeline

Start date
2017-03-01
Primary completion
2019-01-20
Completion
2019-01-20
First posted
2017-07-11
Last updated
2019-01-23

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03212430. Inclusion in this directory is not an endorsement.

The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers (NCT03212430) · Clinical Trials Directory